focu list chang
risk skew upsid upgrad outperform neutral rais target price
build block place solid growth ahead upgrad stm pa outperform neutral rais target price
credit suiss connect seri blockchain cryptocurr begin
brake last mile logist manag meet takeaway rais estim target price
promis year ahead upgrad rate revis estim rais price
ride sec smartphon camera upgrad initi coverag partron outperform rate tp
revis est tp
attract digit play initi coverag outperform rate target price
addit earn power like smartphon price hike
np buy aim oversea safeti profit
factori fire affect motor product earn impact like limit
activ review mqg america
analyst disclosur credit suiss seek busi compani cover research
report result investor awar firm may conflict interest could affect
object report investor consid report singl factor make invest
risk skew upsid upgrad outperform neutral rais target price
follow public dcm consult paper oct oral argument made us suprem
court scotu dec propos acquisit ladbrok coral gvc dec believ risk
skew upsid upgrad outperform
build block place solid growth ahead upgrad stm pa outperform neutral
rais target price
continu believ rise semi content across auto industri even part consum like sensor
continu drive solid growth semi demand ahead benefit volum content growth lead
overal semi industri ex-memori expect volum slowdown content thesi remain intact
credit suiss connect seri blockchain cryptocurr begin
cross-border/sector report analys market implic blockchain technolog underpin cryptocurr
ico boom follow-up blockchain primer blockchain trust disrupt contribut analysts/
global sector secur payment bank exchang busi servic travel leisur estat
brake last mile logist manag meet takeaway rais estim target price
lunch ceo brad jacob tuesday follow remain high convict name see
upsid stock given strong organ growth profil remain under-valued rel peer view
 option two front creat upsid potenti
tax reform product updat center attent approach end tradit one
busier week year pharma/biotech reflect key theme heard compani
promis year ahead upgrad rate revis estim rais price
excit new drug approv expect incom new drug approv major
compani alreadi high failur delay deliv would caus stock price downturn scenario
would prefer compani well track meet high expect market
would like receiv product pleas call product market london
ride sec smartphon camera upgrad initi coverag partron outperform
rate tp revis est tp
bullish sec handset camera suppli chain sec smartphon camera spec well pois upgrad rear
front-end flagship also mid/low-end amid rise competit china handset maker sec dual-
cam penetr rise vs mainli flagship also mid/low
attract digit play initi coverag outperform rate target price
initi coverag persist system outperform tp upsid ebitda growth
mute compound-annual-growth-rate consequ stock under-perform peer last three year
expect chang significantli estim ebitda compound-annual-growth-rate
addit earn power like smartphon price hike
samsung like adopt dual-camera upcom galaxi follow dual camera introduct
galaxi note last year dual camera adopt also go mass market certain higher price
asia ex japan focu list launch mid-april collect strongest bottom-up buy idea
np buy aim oversea safeti profit
nec announc januari acquir uk-bas servic compani northgat public servic limit np
privat equiti firm cinven includ debt ev/ebitda
factori fire affect motor product earn impact like limit
januari fanuc report decemb fire broke one two build fanuc servo
motor manufactur subsidiari base tsu citi mie prefectur
activ review mqg america
gener posit activ trend whilst market volatil level remain subdu mqg invest bank
would like receiv product pleas call product market london
headlin price previou day close unless otherwis note
compani mention price jan
china ltd outperform tp
would like receiv product pleas call product market london
